Human gamma delta T regulatory cells in cancer: fact or fiction?
While gamma delta T cell (γδTc) anticancer immunotherapies are being developed, recent reports suggest a regulatory role for γδTc tumor infiltrating lymphocytes (TIL). This mini-review surveys available evidence, determines strengths and weaknesses thereof and suggest directions for further explorat...
Main Authors: | Daniela eWesch, Christian ePeters, Gabrielle Melanie Siegers |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00598/full |
Similar Items
-
Contemplating Dichotomous Nature of Gamma Delta T Cells for Immunotherapy
by: Jaydeep Bhat, et al.
Published: (2022-05-01) -
Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future
by: José Saura-Esteller, et al.
Published: (2022-06-01) -
Apoptosis Induced via Gamma Delta T Cell Antigen Receptor “Blocking” Antibodies: A Cautionary Tale
by: Indrani Dutta, et al.
Published: (2017-06-01) -
The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers
by: Eline van Diest, et al.
Published: (2023-01-01) -
Natural Self-Ligand Gamma Delta T Cell Receptors (γδTCRs) Insight: The Potential of Induced IgG
by: Thamires Rodrigues de Sousa, et al.
Published: (2020-08-01)